Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ivermectin
Norbrook Laboratories (Ireland) Limited
QP54AA01
Ivermectin
6 milligram(s)/gram
Premix for medicated feeding stuff
POM: Prescription Only Medicine as defined in relevant national legislation
ivermectin
Authorised
2001-11-16
Health Products Regulatory Authority 07 February 2019 CRN008TK5 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Noromectin Premix 6 mg/g Premix for Medicated Feeding Stuff for Swine 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _ACTIVE SUBSTANCE_ Ivermectin 6 mg/g _EXCIPIENTS_ For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Premix for medicated feedingstuff. Free flowing yellow to light brown meal. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is indicated for the treatment of the following gastrointestinal roundworms, lungworms, lice and mange in adult and growing pigs: Gastrointestinal worms: _Ascaris suum _(adults and fourth-stage larvae) _Hyostrongylus rubidus _(adults and fourth-stage larvae) _Oesophagostomum_ spp (adults and fourth-stage larvae) _Strongyloides ransomi_ (adults) Lungworms _Metastrongylus_ spp (adults) Lice: _Haematopinus suis_ Mange mites: _Sarcoptes scabiei_ var_ suis_ Health Products Regulatory Authority 07 February 2019 CRN008TK5 Page 2 of 7 The product given to pregnant sows before farrowing effectively controls transmission via the milk of _S. ransomi_ to piglets. 4.3 CONTRAINDICATIONS Avermectins may not be well tolerated in all non-target species (cases of intolerance with fatal outcome are reported in dogs – especially Collies, Old English Sheepdogs and related breeds or crosses, and also in turtle / tortoises). Do not use in animals known to be hypersensitive to the active substance, or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: - Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosin Read the complete document